IPO Milega

Milega? Check first.

Acme Universal
SMEClosed

Acme Universal

What they do: The company primarily generates revenue through manufacturing and distribution activities, focusing on operational efficiency and market expansion.

By IPO Milega Research · Published · Updated

Check allotment(opens in a new tab)
Our score
6.2/10Strong

The company shows a moderate financial position with steady revenue growth but fluctuating profitability.

GMP (unofficial)
+15.49%
₹11 a share
Subscribed
1.84x
Total
Retail odds
100%
1 in 1

GMP is an unofficial grey market indication.

Price band
₹65-71
Lot size
3200 shares
Min. investment
₹2,27,200
Issue size
36 Cr.
Issue timeline
  1. Open28 Sept 2026
  2. Close30 Sept 2026
  3. Allotment1 Oct 2026
  4. Listing6 Oct 2026

Overview

Your odds

Estimated from the current subscription figures. Tap a category to work it out for your application size.

Subscription by category
1.84x total
QIB
5.7x
NII
0.02x
Retail
0.41x
Estimated listing from GMP (unofficial)

₹82 (+15.49%)

GMP trend

Unofficial grey market quotes, times in IST

Outer ring: estimated gain

How the score adds up

The overall score is the average of these five, nudged by QIB demand once bidding closes.

  • Financials6.0
  • Performance7.0
  • Flexibility7.0
  • Timing7.0
  • Risk4.0
Estimated gain (fundamentals only)
0%

The GMP indicates no premium, suggesting limited immediate gains on listing. The company's moderate financial fundamentals and competitive market position further imply constrained short-term upside potential.

Strengths3

  • Transitioned from a partnership firm to a public limited company.
  • Implemented SAP S/4 HANA for enterprise resource planning.
  • Expanded manufacturing capacity with five facilities.

Concerns5

  • Lease dependencies for offices and factories may disrupt operations.
  • Revenue concentration in few states and customers increases vulnerability.
  • Pending statutory approvals could lead to operational disruptions.
  • High raw material cost volatility affects margins.
  • Outstanding legal proceedings may impact financials.

Who gets shares

Quota split
  • QIB50%
  • NII15%
  • Retail35%
Application size
  • Retail Minimum2,27,200
    2 lots, 3200 shares
  • Retail Maximum2,27,200
    2 lots, 3200 shares
  • S-HNI Minimum3,40,800
    3 lots, 4800 shares
  • S-HNI Maximum9,08,800
    8 lots, 12,800 shares
  • B-HNI Minimum10,22,400
    9 lots, 14,400 shares

Timing

7.0/10

The timing of Acme Universal's IPO appears favorable given the structured allocation strategy and compliance with SEBI regulations. The focus on the SME platform suggests a strategic move to tap into a niche market segment, which could be advantageous in the current economic climate. However, the absence of specific market conditions or economic indicators in the provided text limits a comprehensive assessment.

Time to market
The company's transition from a private to a public entity and the strategic use of the SME platform indicate a well-planned approach to market entry. The regulatory compliance and structured allocation strategy further support a positive timing assessment.
How allotment works
Basis of allotment finalized and shares credited to demat
Market timing
Favourable
Time to market
8.0
Listing on
BSE SME

Key milestones

  1. 28 Sept 2026IPO Opens
  2. 30 Sept 2026IPO Closes
  3. 1 Oct 2026Basis of Allotment
  4. 5 Oct 2026Refunds Initiated
  5. 5 Oct 2026Credit to Demat Account
  6. 6 Oct 2026Listing Date

Financials

6.0/10
Period ended 2026
Change against 2025
Revenue
₹211 Cr
+10.4%
Profit after tax
₹5.86 Cr
+632.5%
Net margin
2.8%
+2.4 pts
Assets
₹147 Cr
+9.7%
Return on equity
11.1
Debt to equity
1.73
Current ratio
1.12
Revenue CAGR
7.2%
ROCE
5.54%
Return on net worth
11.75%
NAV per share (₹)
37.60

Financial performance trend

Amount ₹ in crores

The company shows a moderate financial position with steady revenue growth but fluctuating profitability. The balance sheet reflects a high level of current liabilities, impacting liquidity ratios.

Risk

4.0/10

Read this score as a safety rating: 10/10 means the lowest risk, 1/10 the highest.

Where the risks sit

  • Financial risks3
  • Market risks2
  • Operational risks3
  • Regulatory risks2

High operational and financial risks due to lease dependencies, customer concentration, and regulatory compliance issues.

How the company offsets these

Diversify customer base and geographic revenue sources; strengthen compliance and regulatory processes.

Financial risks3

  • High raw material cost volatility affects margins.
  • Outstanding legal proceedings may impact financials.
  • Credit risk from customers affects cash flow.

Market risks2

  • Revenue concentration in few states and customers increases vulnerability.
  • US tariffs and geopolitical tensions affect export strategy.

Operational risks3

  • Lease dependencies for offices and factories may disrupt operations.
  • Pending statutory approvals could lead to operational disruptions.
  • High dependence on key raw materials affects cost structure.

Regulatory risks2

  • Pending statutory approvals could lead to operational disruptions.
  • Delays in statutory dues may lead to penalties.

Performance

7.0/10

Acme Universal Safezone 9 Limited, a manufacturer of industrial safety footwear, has shown moderate growth and operational efficiency. The company has a strong domestic presence and is expanding its export markets. It operates five manufacturing facilities and utilizes advanced technology for production. Despite facing competition, it maintains a competitive edge through quality and compliance with international standards.

Historical growth
The company has shown consistent revenue growth over the past three years, with a CAGR of approximately 7.3%., Moderate
Market comparison
The company operates in a competitive market with both organized and unorganized players. It differentiates itself through quality and compliance with international standards, but faces competition from larger firms with more resources.
Future potential
The company is expected to continue its growth trajectory by expanding its export markets and increasing production capacity.
Operational consistency
The company's consistent revenue growth and operational expansion indicate stable performance.
Management quality
8.0/10
Experience
The management team, led by promoters Nitin and Ruchi Tiwari, has extensive experience in the safety footwear industry.
Track record
The management has successfully expanded the company's operations and market reach.

Key achievements

  1. 01Transitioned from a partnership firm to a public limited company.
  2. 02Implemented SAP S/4 HANA for enterprise resource planning.
  3. 03Expanded manufacturing capacity with five facilities.

Flexibility

7.0/10
Market adaptability
6.0/10

The company has a strong domestic presence and is expanding internationally, but faces high competition and relies heavily on a few key markets.

Operational agility
8.0/10

The company has automated key production processes and uses advanced technology, enhancing its operational efficiency and ability to scale.

Acme Universal Safezone 9 Limited demonstrates moderate flexibility and adaptability, with strengths in operational agility and product diversification, but faces challenges in financial stability and market adaptability.

Product diversification
The company offers a wide range of safety footwear products catering to various industrial needs, including impact protection, chemical resistance, and electrical safety.
Future adaptability
The company is investing in solar power and new machinery to enhance sustainability and efficiency, indicating potential for future adaptability.

The data on this page has been reviewed manually by the IPO Milega research team. It is not investment advice, and IPO Milega accepts no responsibility for losses arising from any investment decision. Investments in the securities market are subject to market risks. Read all the related documents, including the full prospectus, carefully before investing.